European Medicinal Agency (EMA) told about the procedure for evaluating vaccines, RIA Novosti reports.
“We cannot disclose information about a specific verification, as this may prevent the achievement of its goals. However, we can explain the overall steps,” they told in the agency.
It is noted that the objects of companies inside and outside the European Union (EU), which are involved in the development, production and distribution of drugs intended for the European market, are regularly checked by the EU authorities to make sure their compliance with the current standards.
In the course of the inspection, specialists certify the reliability and completeness of data that confirm the resolution of vaccines in the EU, as well as their quality, safety and efficiency after entering the market.
in EMA added that inspections are carried out both in relation to drugs already having permission in the European Union and in relation to funds that are currently taking place to obtain such permission.
Earlier it was reported that the European Medicine Agency (EMA) in April will send an inspection to Russia to verify the “satellite V”. Check will affect the issues related to clinical trials and the production of the Russian drug.